The dendritic cells trained by NWBO technology is not picky at all. It can swallow lysate from tumors on human, mice, dog and other mammals. Recall what Les said about patients with 15 types of tumors.
Seems to me NWBO only needs to take care of different immunosuppressive characteristics which can be tumor type dependent. Of course, you know that NWBO has the technology to increase t cell counts.
Market Data 
Markets 
AI
